Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.35
Bid: 40.00
Ask: 52.00
Change: 0.00 (0.00%)
Spread: 12.00 (30.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.35
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Old Mutual plc - Results from bondholder meetings

12 Nov 2018 12:15

RNS Number : 0704H
Old Mutual Limited
12 November 2018
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

NSX Share Code: OMM

("Old Mutual")

 

Ref 74/2018

12 November 2018

NOT FOR DISTRIBUTION INTO ANY JURISDICTION OR TO ANY PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

RESULTS OF BONDHOLDER MEETINGS

 

OLD MUTUAL SUBSIDIARY OLD MUTUAL PLC ANNOUNCES (I) THE RESULTS OF SEPARATE ADJOURNED NOTEHOLDER MEETINGS OF ITS OUTSTANDING £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 TO APPROVE BY WAY OF EXTRAORDINARY RESOLUTION CERTAIN MODIFICATIONS TO THE TERMS AND CONDITIONS OF THE RELEVANT SERIES AND THE RELEVANT TRUST DEED CONSTITUTING THE RELEVANT SERIES AND (II) THE EXECUTION OF SUPPLEMENTAL TRUST DEEDS

 

The body of the Old Mutual plc announcement (as published on the London Stock Exchange website) is set out below.

----------------------------------------------------------------------------------------------------------------------------------

Old Mutual plc (the "Company") announces (I) THE RESULTS OF SEPARATE ADJOURNED NOTEHOLDER MEETINGS of its outstanding £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 (the "2021 Securities") AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 (the "2025 Securities" and, together with the 2021 Securities, the "Securities", and each a "Series") (the "adjourned meetings") to approve by way of extraordinary resolution certain modifications to the terms and conditions of the relevant series and the relevant trust deed constituting the relevant series AND (II) THE EXECUTION OF SUPPLEMENTAL TRUST DEEDS

On 26 September 2018, the Company announced its separate invitations to holders of its 2021 Securities (the "2021 Securityholders") and to holders of its 2025 Securities (the "2025 Securityholders" and, together with the 2021 Securityholders, the "Securityholders") in each case to approve, by way of Extraordinary Resolution, the relevant Proposal, comprising certain modifications to the terms and conditions of the relevant Series (in respect of such Series, the "Conditions") and the trust deed constituting the relevant Series as further detailed in the Consent Solicitation Memorandum dated 26 September 2018 (the "Consent Solicitation Memorandum"), subject, in each case, to the terms and conditions set out in the Consent Solicitation Memorandum, as amended by the announcement of the Company dated 25 October 2018 announcing the convening of the Adjourned Meetings (the "Adjourned Meetings Announcement"). Capitalised terms used in this announcement but not defined have the meanings given to them in the Consent Solicitation Memorandum (as amended by the Adjourned Meetings Announcement).

The Consent Deadline expired at 4.00 p.m. (London time) on 7 November 2018.

Results of the Proposals

The Adjourned Meetings to consider the Proposals were held earlier today, and NOTICE IS HEREBY GIVEN to Securityholders that:

(a) at the Adjourned Meetings, the relevant Extraordinary Resolutions were duly passed and the relevant Proposals approved;

(b) the relevant Supplemental Trust Deeds referred to in the relevant Extraordinary Resolutions have been executed by the Company and the Trustee, and the relevant Conditions have been amended accordingly;

(c) the Reference Gilt Rates are expected to be determined at or around 11.00 a.m. (London Time) on 13 November 2018 and the Company will announce the Early Redemption Amount in respect of each series of Notes as soon as reasonably practicable thereafter; and

(d) the Company will redeem all Notes of each Series pursuant to the Issuer Early Redemption on 15 November 2018 (the "Settlement Date") at the Early Redemption Amount plus Accrued Interest (if any).

All Securities which are redeemed pursuant to the Issuer Early Redemption will forthwith be cancelled. Securityholders who delivered, or arranged to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution which was received by the Tabulation Agent by the Consent Deadline will also receive the Consent Fee on the Settlement Date.

Requests for information in relation to the Consent Solicitation and the Proposals should be directed to:

The Solicitation Agent

Merrill Lynch International

2 King Edward Street

London EC1A 1HQ

United Kingdom

 

Telephone: +44 20 7996 5420

Attention: Liability Management Group

Email: DG.LM_EMEA@baml.com

 

The Tabulation Agent

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

 

Telephone: + 44 20 7704 0880

Attention: Arlind Bytyqi

Email: oldmutual@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Consent Solicitation Memorandum (as amended by the Adjourned Meetings Announcement). No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement, the Adjourned Meetings Announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Adjourned Meetings Announcement and/or the Consent Solicitation Memorandum comes are required by each of the Company, the Solicitation Agent and the Tabulation Agent to inform themselves about, and to observe, any such restrictions.

 

----------------------------------------------------------------------------------------------------------------------------------

 

JSE Sponsor

Merrill Lynch South Africa (Pty) Limited

Namibian Sponsor

PSG Wealth Management (Namibia) (Proprietary) Limited

Enquiries

Investor Relations

Patrick Bowes

(Interim Head of Investor Relations)

 

T: +44 (0)20 7002 7440

E: Patrick.bowes@omg.co.uk

Communications:

Tabby Tsengiwe

 

T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

 

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 17 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has niche businesses in Latin America and Asia. With over 170 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMLLFVLLTLFLIT
Date   Source Headline
14th Feb 202410:30 amRNSForm 8.3 - Mondi Plc
13th Feb 202411:00 amRNSForm 8.3 - Mondi Plc
2nd Jan 20243:00 pmRNSDealings in securities on behalf of Share Trusts
27th Dec 20233:00 pmRNSDealings in securities on behalf of ESIS
21st Dec 20233:00 pmRNSChange of the JSE Equity Sponsor
20th Dec 20233:30 pmRNSDealings in securities on behalf of ESIS
19th Dec 20233:30 pmRNSSecurities dealings on behalf of ESIS
12th Dec 20233:45 pmRNSChange in JSE equity sponsor
5th Dec 20233:45 pmRNSDirectorate Change
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
30th Nov 202311:00 amRNSDirector/PDMR Shareholding
22nd Nov 20238:00 amRNSOld Mutual Limited Voluntary Operating Update
9th Nov 20233:00 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
26th Oct 20234:30 pmRNSOld Mutual Share Repurchase programme
25th Oct 20234:30 pmRNSDealings in securities on behalf of ESIS
20th Oct 20234:00 pmRNSDealings in securities on behalf of ESIS
17th Oct 20232:30 pmRNSDealing in securities on behalf of ESIS
3rd Oct 20239:00 amRNSFinalisation and dividend currency equivalents
27th Sep 20237:00 amRNSUnaudited Interim Results and Dividend Declaration
13th Sep 20237:00 amRNSVoluntary Trading Statement
28th Jul 20237:00 amRNSInvestor update and release of information
30th May 202310:00 amRNSOld Mutual Share Repurchase Programme
30th May 20237:00 amRNSResult of AGM
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
25th May 202311:40 amRNSVoluntary Operating Update
18th May 20231:30 pmRNSForm 8.3 - Mediclinic International plc
11th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
4th May 20231:45 pmRNSForm 8.3 - Mediclinic International plc
27th Apr 20232:00 pmRNSForm 8.3 - Mediclinic International plc
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.